Requiere autenticación

Dithiothreitol treatment of red blood cells

   | 16 oct 2019

Cite

Fung MK, Grossman BJ, Hillyer CD, Westhoff CM. Technical manual. 19th ed. Bethesda, MD: American Association of Blood Banks, 2017: Method 3–18.Search in Google Scholar

Branch DR, Muensch HA, Sy Siok Hian S, Petz LD. Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Br J Haematol 1983;54:573–8.10.1111/j.1365-2141.1983.tb02136.x6871108Search in Google Scholar

Reid ME, Lomas-Francis C, Olsson M. The blood group antigen factsbook. 3rd ed. London:Elsevier Academic Press, 2012.10.1016/B978-0-12-415849-8.00026-0Search in Google Scholar

Fung MK, Grossman BJ, Hillyer CD, Westhoff CM. Eds. Technical manual. 19th ed. Bethesda, MD: American Association of Blood Banks, 2017: Method 2–18.Search in Google Scholar

Murphy MF, Dumont LJ, Greinacher A. Interference of new drugs with compatibility testing for blood transfusion. N Engl J Med 2016;375:295–6.10.1056/NEJMc151596927468082Search in Google Scholar

Chapuy CI, Aguad MD, Nicholson RT, Aubuchon JP, Cohn CS, Delaney M, et al. International validation of a dithiothreitol (DTT)-based method to resolve the daratumumab interference with blood compatibility testing. Transfusion 2016;56:2964–72.10.1111/trf.1378927600566Search in Google Scholar

Disbro WL. Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab. Immunohematology 2017;33:105–9.10.21307/immunohematology-2019-015Search in Google Scholar

eISSN:
1930-3955
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, Laboratory Medicine